Upregulated miR-132 in Lgr5 gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway. (Q48312418)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 April 2017
edit
Language Label Description Also known as
English
Upregulated miR-132 in Lgr5 gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway.
scientific article published on 6 April 2017

    Statements

    Upregulated miR-132 in Lgr5 gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit